378 related articles for article (PubMed ID: 27289487)
21. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
Lees KR; Bluhmki E; von Kummer R; Brott TG; Toni D; Grotta JC; Albers GW; Kaste M; Marler JR; Hamilton SA; Tilley BC; Davis SM; Donnan GA; Hacke W; ; Allen K; Mau J; Meier D; del Zoppo G; De Silva DA; Butcher KS; Parsons MW; Barber PA; Levi C; Bladin C; Byrnes G
Lancet; 2010 May; 375(9727):1695-703. PubMed ID: 20472172
[TBL] [Abstract][Full Text] [Related]
22. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial.
Zinkstok SM; Roos YB;
Lancet; 2012 Aug; 380(9843):731-7. PubMed ID: 22748820
[TBL] [Abstract][Full Text] [Related]
23. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial.
Hanley DF; Thompson RE; Muschelli J; Rosenblum M; McBee N; Lane K; Bistran-Hall AJ; Mayo SW; Keyl P; Gandhi D; Morgan TC; Ullman N; Mould WA; Carhuapoma JR; Kase C; Ziai W; Thompson CB; Yenokyan G; Huang E; Broaddus WC; Graham RS; Aldrich EF; Dodd R; Wijman C; Caron JL; Huang J; Camarata P; Mendelow AD; Gregson B; Janis S; Vespa P; Martin N; Awad I; Zuccarello M;
Lancet Neurol; 2016 Nov; 15(12):1228-1237. PubMed ID: 27751554
[TBL] [Abstract][Full Text] [Related]
25. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study.
Sylaja PN; Cote R; Buchan AM; Hill MD;
J Neurol Neurosurg Psychiatry; 2006 Jul; 77(7):826-9. PubMed ID: 16505004
[TBL] [Abstract][Full Text] [Related]
26. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.
Kvistad CE; Næss H; Helleberg BH; Idicula T; Hagberg G; Nordby LM; Jenssen KN; Tobro H; Rörholt DM; Kaur K; Eltoft A; Evensen K; Haasz J; Singaravel G; Fromm A; Thomassen L
Lancet Neurol; 2022 Jun; 21(6):511-519. PubMed ID: 35525250
[TBL] [Abstract][Full Text] [Related]
27. Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial.
Berge E; Cohen G; Roaldsen MB; Lundström E; Isaksson E; Rudberg AS; Slot KB; Forbes J; Smith J; Drever J; Wardlaw JM; Lindley RI; Sandercock PA; Whiteley WN;
Lancet Neurol; 2016 Sep; 15(10):1028-34. PubMed ID: 27450474
[TBL] [Abstract][Full Text] [Related]
28. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.
Hanley DF; Lane K; McBee N; Ziai W; Tuhrim S; Lees KR; Dawson J; Gandhi D; Ullman N; Mould WA; Mayo SW; Mendelow AD; Gregson B; Butcher K; Vespa P; Wright DW; Kase CS; Carhuapoma JR; Keyl PM; Diener-West M; Muschelli J; Betz JF; Thompson CB; Sugar EA; Yenokyan G; Janis S; John S; Harnof S; Lopez GA; Aldrich EF; Harrigan MR; Ansari S; Jallo J; Caron JL; LeDoux D; Adeoye O; Zuccarello M; Adams HP; Rosenblum M; Thompson RE; Awad IA;
Lancet; 2017 Feb; 389(10069):603-611. PubMed ID: 28081952
[TBL] [Abstract][Full Text] [Related]
29. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
Menon BK; Buck BH; Singh N; Deschaintre Y; Almekhlafi MA; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar J; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra S; Gioia LC; Jalini S; Cayer C; Phillips S; Elamin E; Shoamanesh A; Subramaniam S; Kate M; Jacquin G; Camden MC; Benali F; Alhabli I; Bala F; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe A; Sehgal A; Zhang Q; Lethebe BC; Doram C; Ademola A; Shamy M; Kenney C; Sajobi TT; Swartz RH;
Lancet; 2022 Jul; 400(10347):161-169. PubMed ID: 35779553
[TBL] [Abstract][Full Text] [Related]
30. Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.
Anderson CS; Robinson T; Lindley RI; Arima H; Lavados PM; Lee TH; Broderick JP; Chen X; Chen G; Sharma VK; Kim JS; Thang NH; Cao Y; Parsons MW; Levi C; Huang Y; Olavarría VV; Demchuk AM; Bath PM; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Ricci S; Roffe C; Pandian J; Billot L; Woodward M; Li Q; Wang X; Wang J; Chalmers J;
N Engl J Med; 2016 Jun; 374(24):2313-23. PubMed ID: 27161018
[TBL] [Abstract][Full Text] [Related]
31. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L
Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236
[TBL] [Abstract][Full Text] [Related]
32. Hyperdense middle cerebral artery sign on admission CT scan--prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register.
Kharitonova T; Ahmed N; Thorén M; Wardlaw JM; von Kummer R; Glahn J; Wahlgren N
Cerebrovasc Dis; 2009; 27(1):51-9. PubMed ID: 19018138
[TBL] [Abstract][Full Text] [Related]
33. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Dewey HM; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi CR; Rodrigues E; Zhao H; Salvaris P; Garcia-Esperon C; Bailey P; Rice H; de Villiers L; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Wong AA; Muller C; Coulthard A; Mitchell K; Clouston J; Mahady K; Field D; Ma H; Phan TG; Chong W; Chandra RV; Slater LA; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
N Engl J Med; 2018 Apr; 378(17):1573-1582. PubMed ID: 29694815
[TBL] [Abstract][Full Text] [Related]
34. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
35. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
Chen HS; Cui Y; Zhou ZH; Zhang H; Wang LX; Wang WZ; Shen LY; Guo LY; Wang EQ; Wang RX; Han J; Dong YL; Li J; Lin YZ; Yang QC; Zhang L; Li JY; Wang J; Xia L; Ma GB; Lu J; Jiang CH; Huang SM; Wan LS; Piao XY; Li Z; Li YS; Yang KH; Wang DL; Nguyen TN;
JAMA; 2023 Jun; 329(24):2135-2144. PubMed ID: 37367978
[TBL] [Abstract][Full Text] [Related]
36. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.
Wardlaw JM; Koumellis P; Liu M
Cochrane Database Syst Rev; 2013 May; 2013(5):CD000514. PubMed ID: 23728633
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials.
Wang Y; Cai X; Fang Q; Zhu J
J Neurol Sci; 2024 Mar; 458():122912. PubMed ID: 38325064
[TBL] [Abstract][Full Text] [Related]
38. Intravenous alteplase for stroke in those older than 80 years old.
Ford GA; Ahmed N; Azevedo E; Grond M; Larrue V; Lindsberg PJ; Toni D; Wahlgren N
Stroke; 2010 Nov; 41(11):2568-74. PubMed ID: 20930163
[TBL] [Abstract][Full Text] [Related]
39. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
Diedler J; Ahmed N; Sykora M; Uyttenboogaart M; Overgaard K; Luijckx GJ; Soinne L; Ford GA; Lees KR; Wahlgren N; Ringleb P
Stroke; 2010 Feb; 41(2):288-94. PubMed ID: 20056933
[TBL] [Abstract][Full Text] [Related]
40. Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke.
Ma H; Campbell BCV; Parsons MW; Churilov L; Levi CR; Hsu C; Kleinig TJ; Wijeratne T; Curtze S; Dewey HM; Miteff F; Tsai CH; Lee JT; Phan TG; Mahant N; Sun MC; Krause M; Sturm J; Grimley R; Chen CH; Hu CJ; Wong AA; Field D; Sun Y; Barber PA; Sabet A; Jannes J; Jeng JS; Clissold B; Markus R; Lin CH; Lien LM; Bladin CF; Christensen S; Yassi N; Sharma G; Bivard A; Desmond PM; Yan B; Mitchell PJ; Thijs V; Carey L; Meretoja A; Davis SM; Donnan GA;
N Engl J Med; 2019 May; 380(19):1795-1803. PubMed ID: 31067369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
